share_log

Industrial Alliance Initiates Coverage On NervGen Pharma with Speculative Buy Rating, Announces Price Target of $6

Industrial Alliance Initiates Coverage On NervGen Pharma with Speculative Buy Rating, Announces Price Target of $6

产业联盟以投机性买入评级启动对NervGen Pharma的覆盖,宣布目标价为6美元
Benzinga Real-time News ·  2021/07/13 20:55

Industrial Alliance initiates coverage on NervGen Pharma (OTC:NGENF) with a Speculative Buy rating and announces Price Target of $6.

工业联盟以投机性买入评级启动对NervGen Pharma(场外交易代码:NGENF)的保险,并宣布目标价为6美元。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发